No major association between TGFBR1*6A and prostate cancer

BMC Genetics

Volumn 5, Issue , 2004, Pages

  Kaklamani, Virginia ^a   Baddi, Lisa ^a   Rosman, Diana ^a   Liu, Junjian ^a   Ellis, Nathan ^b   Oddoux, Carole ^c   Ostrer, Harry ^c   Chen, Yu ^d   Ahsan, Habibul ^d   Offit, Kenneth ^b   Pasche, Boris ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^d Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1 6A; UNCLASSIFIED DRUG; ACTIVIN RECEPTOR 1; PROTEIN SERINE THREONINE KINASE; TGF BETA TYPE I RECEPTOR; TGF-BETA TYPE I RECEPTOR;

ADULT; AGED; ARTICLE; CITY; CONTROLLED STUDY; DATA ANALYSIS; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PROSTATE CANCER; STATISTICAL SIGNIFICANCE; UNITED STATES; ALLELE; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; PROSTATE TUMOR;

ACTIVIN RECEPTORS, TYPE I; ADULT; AGED; AGED, 80 AND OVER; ALLELES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA;

EID: 25444506226     PISSN: 14712156     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2156-5-28     Document Type: Article

References (10)

1. Siegel PM, Massague J: Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer. Nat Rev Cancer 2003, 3:807-820.
2. Bian Y, Kaklamani V, Reich J, Pasche B: TGF-beta signaling alterations in cancer. Cancer Treat Res 2003, 115:73-94.
3. Pasche B, Luo Y, Rao PH, Nimer SD, Dmitrovsky E, Caron P, Luzzatto L, Offit K, Cordon-Cardo C, Renault B, Satagopan JM, Murty VV, Massague J: Type I transforming growth factor beta receptor maps to 9q22 and exhibits a polymorphism and a rare variant within a polyalanine tract. Cancer Res 1998, 58:2727-2732.
4. Chen T, de Vries EG, Hollema H, Yegen HA, Vellucci VF, Strickler HD, Hildesheim A, Reiss M: Structural alterations of transforming growth factor-beta receptor genes in human cervical carcinoma. Int J Cancer 1999, 82:43-51.
5. Pasche B, Kolachana P, Nafa K, Satagopan J, Chen YG, Lo RS, Brener D, Yang D, Kirstein L, Oddoux C, Ostrer H, Vineis P, Varesco L, Jhanwar S, Luzzatto L, Massague J, Offit K: T beta R-I(6A) is a candidate tumor susceptibility allele. Cancer Res 1999, 59:5678-5682.
6. Kaklamani Virginia G., Hou Nanjiang, Bian Yiansong, Reich Jennifer, Offit Kenneth, Michel Loren S., Rubinstein WS, Rademaker Alfred, Pasche Boris: TGFBR1*6A and Cancer Risk: A Meta-Analysis of Seven Case-Control Studies. J Clin Oncol 2003, 21:3236-3243.
7. Pasche Boris, Kaklamani Virginia G., Hou Nanjiang, Young Taya, Rademaker Alfred, Peterlongo Paolo, Ellis Nathan, Offit Kenneth, Caldes Trinidad, Reiss Michael, Zheng Tongzhang: TGFBR1*6A and Cancer: A Meta-Analysis of 12 Case-Control Studies. J Clin Oncol 2004, 22:756-758.
8. Jemal Ahmedin, Tiwari Ram C., Murray Taylor, Ghafoor Asma, Samuels Alicia, Ward Elizabeth, Feuer Eric J., Thun Michael J.: Cancer Statistics, 2004. Ca: a Cancer Journal for Clinicians 2004, 54:8-29.
9. Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, Pukkala E, Skytthe A, Hemminki K: Environmental and heritable factors in the causation of cancer - Analyses of cohorts of twins from Sweden, Denmark, and Finland. N E J Med 2000, 343:78-85.
10. Edwards SM, Kote-Jarai Z, Meitz J, Hamoudi R, Hope Q, Osin P, Jackson R, Southgate C, Singh R, Falconer A, Dearnaley DP, Ardern-Jones A, Murkin A, Dowe A, Kelly J, Williams S, Oram R, Stevens M, Teare DM, Ponder BA, Gayther SA, Easton DF, Eeles RA: Two Percent of Men with Early-Onset Prostate Cancer Harbor Germline Mutations in the BRCA2 Gene. Am J Hum Genet 2003, 72:1-12.